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Background: With an average prescription rate of 50%, in German primary care antibiotics are still too frequently
prescribed for respiratory tract infections. The over-prescription of antibiotics is often explained by perceived patient
pressure and fears of a complicated disease progression. The CHANGE-2 trial will test the effectiveness of two
interventions to reduce the rate of inappropriate antibiotic prescriptions for adults and children suffering from
respiratory tract infections in German primary care.
Methods/Design: The study is a three-arm cluster-randomized controlled trial that measures antibiotic prescription
rates over three successive winter periods and reverts to administrative data of the German statutory health
insurance company AOK. More than 30,000 patients in two regions of Germany, who visit their general practitioner
or pediatrician for respiratory tract infections will be included. Interventions are: A) communication training for
general practitioners and pediatricians and B) intervention A plus point-of-care testing. Both interventions are tested
against usual care. Outcome measure is the physicians’ antibiotic prescription rate for respiratory tract infections
derived from data of the health insurance company AOK. Secondary outcomes include reconsultation rate,
complications, and hospital admissions.
Discussion: Major aim of the study is to improve the process of decision-making and to ensure that patients who
are likely to benefit from antibiotics are treated accordingly. Our approach is simple to implement and might be
used rapidly among general practitioners and pediatricians. We expect the results of this trial to have major impact
on antibiotic prescription strategies and practices in Germany, both among general practitioners and pediatricians.
Trial registration: The study is registered at the Current Controlled Trials Ltd (ISRCTN01559032)
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With an average prescription rate of 50%, in German
primary care antibiotics are still too frequently pre-
scribed for respiratory tract infections (RTI) [1,2]. Even
among children, prescription of antibiotics by general
practitioners (GPs) and pediatricians is extensive [3], al-
though it is recognized that antibiotics are very unlikely* Correspondence: annette.diener@med.uni-rostock.de
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reproduction in any medium, provided the orto alter the course of RTI, such as throat infections,
acute otitis media, maxillary sinusitis, and acute bron-
chitis [4,5]. Consequently, current guidelines advise
against the use of antibiotics during the initial treatment
of uncomplicated RTI in otherwise healthy children and
adults. These guidelines take potential side effects,
medicalization for self-limiting conditions, increasing re-
sistance to respiratory pathogens, and costs of unneces-
sary antibiotic treatment into account [6-9].
Explanations for the inappropriate use of antibiotics in
RTIs focus on perceived patient expectations, efforts toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ease, and inadequate knowledge of physicians [10-14].
Although there is evidence that patients expect anti-
biotic prescriptions less often than physicians believe
[15,16], and that a properly communicated reduction of
antibiotic prescriptions does not affect patient satisfac-
tion [17,18], perceived patient pressure, expectations and
satisfaction remain major factors influencing the deci-
sion whether to prescribe antibiotics or not. During con-
sultations patients often express their worries about
symptoms and desire reassurance about the harmless-
ness of their medical condition. Quite often this per-
ceived pressure leads to unnecessary prescriptions of
antibiotics [2,13,15,19-21]. Receiving antibiotics in turn
reinforces patients’ beliefs that antibiotics are powerful
agents against uncomplicated RTI and strengthens the
assumption that future RTI should be treated equally
[4,22]. This results in a vicious circle of antibiotic
prescription.
Also, diagnostic uncertainty is often mentioned when
discussing inappropriate use of antibiotic prescriptions.
Studies have shown that clinical indicators such as col-
ored nasal discharge or colored sputum significantly in-
fluence prescribing behavior [23]. However, there is only
weak evidence that a yellowish or greenish color is a
good diagnostic marker for bacterial infection [24,25].
Notwithstanding, GPs still tend to overestimate the like-
lihood of bacterial infection when evaluating the import-
ance of colored nasal discharge or sputum, leading to
increased numbers of antibiotic prescriptions [23].
In the past, numerous trials aimed at optimizing anti-
biotic prescribing in primary care. Most of them focus
on two central problems related to inadequate prescrib-
ing: insufficient physician-patient-communication and
diagnostic uncertainty. Promising approaches range
from feedback on prescriptions and computer-based de-
cision aids [26,27] to communication skills training and
point-of-care tests (POCTs) [28,29]. Also, some studies
employ the strategy of delayed prescribing. Little and
colleagues, for instance, did not prescribe antibiotics in
the initial consultation when a viral etiology for acute
lower respiratory tract infections was very likely. If,
14 days later, symptoms were not resolved, patients had
the opportunity to take a course of antibiotics without
reconsultation. This led to a reduction of antibiotic use.
Also, patients were less likely to believe in the effective-
ness of antibiotics [18].
POCTs are useful to increase diagnostic certainty and
help to predict the likelihood of serious bacterial RTI
such as pneumonia. POCTs measure inflammatory mar-
ker proteins (C-reactive protein [CRP] or procalcitonin).
These can be combined with clinical parameters. Other
POCTs are fast pathogen identification tests such as
rapid streptococcal A antigen detection test (RADT) thatindicate benefit from treatment with penicillin [8]. A re-
cent evaluation of an RADT documented a specificity of
98% and a sensitivity of 70%. The latter reached up to
85% when a clinical scoring system (McIsaac score) was
implemented to enhance pretest probability [30].
As mentioned above, in a number of recent studies
communication training proved to be successful
[1,31,32]. In a previous study, we were able to demon-
strate a sustained effect of 40% relative reduction of anti-
biotic prescription for acute cough by motivating GPs to
change their doctor-patient communication and by
empowering patients [1]. In the Netherlands, Cals et al.
conducted a cluster-randomized trial and were able to
show that a training in communication skills or POCT
for CRP and a combination of both significantly reduced
antibiotic prescribing for RTI. Interestingly, these results
were obtained without negative impact on patients’ re-
covery or patient satisfaction [31]. After termination of
the trial those physicians who had experience with both
interventions were asked about their preferences to
manage lower respiratory tract infections. The majority
preferred communication skills training to CRP meas-
urement. However, they recognized CRP testing as a
useful additional tool to improve diagnostic certainty
[33]. Thus, POCTs might be used as an “add on” to
physician communication training in order to decrease
unnecessary antibiotic prescribing for acute cough.
Based on these findings, the CHANGE-2 trial will test
the effectiveness of two interventions aiming at the re-
duction of inappropriate antibiotic prescriptions for
adults and children suffering from RTI in primary care.
Intervention A includes communication training. Inter-
vention A+B combines communication training with
point-of-care testing. Care as usual serves as control.
This is the first trial assessing the effectiveness of the
described interventions in a systematic way in Germany.
Our primary aim is to improve the decision-making
process, but not to reduce antibiotic prescriptions at all
costs. This approach ensures that patients who may
benefit from antibiotics will be treated accordingly. The
trial design allows a comprehensive patient follow-
up ensuring that adverse effects of the intended reduc-
tion in antibiotic prescription (e.g. hospital admissions)
can be monitored. Also, the follow-up will allow for




The CHANGE-2 trial is a three arm cluster-randomized
controlled trial that measures antibiotic prescription
rates over three successive winter periods and reverts to
administrative data of the German statutory health in-
surance company AOK.
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Clusters will consist of participating primary care physi-
cians who will be randomized into three groups: Inter-
vention A (communication training), intervention A+B
(communication training + POCT), and control. Com-
munication training will be organized within one-time
small group sessions and will focus on the following
topics: Patient expectations, shared decision-making
(SDM), and the concept and use of delayed prescribing.
In particular, participating physicians will ameliorate
their communication techniques in order to explore
patients’ (or parents’) expectations. Also, they will be
trained in patients’ concepts of disease and patients’ ac-
tual needs, e.g. ruling out a serious disease or pain relief
[34,35]. This concept incorporates the principles of
shared decision-making, without weakening the role of
the primary care physician [36]. Furthermore, an
adapted concept of delayed prescribing will be presented
to participating physicians. This concept might be useful
for those (rare) cases in which – despite communication
training – the issue of antibiotic prescription cannot be
solved in a satisfactory manner.
Physicians randomized into intervention A+B will be
encouraged to use POCT kits (CRP and RADT) when
appropriate. These will be provided free of charge. Physi-
cians and their practice staff will be trained on how to
use these test kits and how to judge which patients
might benefit from POCTs. Among intervention A+B
we expect up to 15% of patients to be tested with RADT,
and up to 40% of patients to be tested with CRP.
Randomization
The study is carried out in primary health care facilities
of the two German regions of Baden-Württemberg and
Mecklenburg-Western Pomerania. Clusters will consist
of general practitioners or practice-based pediatricians
and their patients, who ask for consultation due to acute
respiratory infection. Using complete and current lists of
general practitioners and practice-based pediatricians
provided by the Associations of Statutory Health Insur-
ance Physicians of both regions potential participants
will be contacted. Interested GPs and pediatricians will
be cluster-randomized to intervention A, A+B or
control.
Study population and recruitment
Patients will be recruited in the practices of participating
physicians at three points in time: during a three months
period in winter at baseline (T0), one year after baseline
after the educational intervention (T1) and two years
after baseline (T2). Diagnosis and relevant results of
clinical examination will be documented. From previous
studies we know that in German primary care during
winter season a primary care physician sees on average20 patients per week who suffer from RTI. This number
might increase up to 30–50 patients during peak peri-
ods. However, for our calculations we rely on a conser-
vative estimation of 15 patients per week. Within a
typical primary care setting of the two considered re-
gional areas, at least 40% of all patients are insured with
AOK. As a result, we assume to recruit at least 6
patients per week. Each recruitment period (baseline, T1
and T2) will last 12 work weeks (excluding holidays).
Thus, we expect about 70 eligible patients to be included
per participating primary care physician. For smaller
practices that might face difficulties recruiting this num-
ber of patients, we allow for the extension of the recruit-
ment period for up to 8 weeks (thus, 20 weeks in total).
The personnel of the participating practices will not be
involved in the collection of outcome relevant data.
Inclusion criteria for patients are: health insurance
with the AOK, 3 months minimum age, physician con-
sultation visit due to the first episode of acute RTI
(upper respiratory tract infection [URTI] and lower re-
spiratory tract infection [LRTI]) according to the ICD
classes: J00-J04, J06, J13, J20, J22, otherwise healthy. This
definition will include all typical acute RTI including
bronchitis, tonsillopharyngitis (e.g. sore throat), and oti-
tis media. Participants are required to give informed
consent that includes the acceptance of scientific use of
relevant data stored at the AOK.
Patient exclusion criteria are underlying chronic dis-
eases, which may affect the immune status in any rele-
vant matter. This includes malignoma, chronic
obstructive pulmonary diseases, cystic fibrosis, and im-
mune deficiency of other causes.
Aim of the study and outcome measures
The trial assesses the effectiveness of two interventional
approaches to reduce unnecessary antibiotic prescription
in primary care. Primary outcome measure is the phys-
ician antibiotic prescription rate for RTI at study period
T2 derived from the data of the AOK health insurance
company. As secondary outcome measures we will
include reconsultation rate, complications/adverse
effects (including hospital admissions), choice of guide-
line conform antibiotic substance in case one was pre-
scribed. Outcomes will be measured at baseline (T0),
shortly after the interventions took place (T1) and
approximately 12 months after the interventions (T2)
(Figure 1).
Sample size calculation
For power calculations we considered a relative reduc-
tion of the overall antibiotic prescriptions of 30% as
clinically relevant and realistic. Our prior study proved
that by means of specific communication training
among primary care practices a relative reduction of
Figure 1 Flow chart of the CHANGE-2 trial.
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reduction of a prescription rate from 50% to 35% (rela-
tive reduction of 30%) was to be demonstrated with a
power of 80% at a significance level of 1.67% two-sided,
a sample size of 240 per group would be required in a
randomized trial.
The results from our prior study allow us to estimate
the intraclass correlation coefficient (ICC) with high ac-
curacy for the sample size calculation. Assuming an
intraclass correlation of 0.2 and a cluster size of 70
patients [1], this sample size has to be multiplied with a
design factor of 14.8, resulting in a sample size of 10,656
evaluable patients in 152 practices for a 3-arm-trial with
pairwise comparisons. With a practice drop-out rate
from T0 to T1 of 10% and again of 10% from T1 to T2,
a total sample size of 13,160 patients in 188 practices
has to be recruited for the study at baseline to en-
sure that at T2 152 practice-based physicians with
10,640 patients can be analyzed.Statistical analyses
For the primary endpoint a generalized multi-level
model, that takes the randomized clusters (practices) as
random effect into account, with antibiotic prescription
rate at T2 as dependent and random group as independ-
ent variable, will be fitted to the data. Baseline (T0) anti-
biotic rates and a selection of further baseline
characteristics of physician or patient will function as
covariates. Points to consider on adjustment for baseline
covariates on patient level will be amongst others sever-
ity of illness on a 4-point scale, fever, patient smoking or
not, duration of symptoms before seeing the doctor and
patient’s age [37]. The intervention effects are quantified
by the between-groups odds ratios of the corresponding
estimates of changes from baseline from the fully
adjusted model, which we assume to give the best ac-
count of the study results. The primary analysis will con-
sist of the three pairwise comparisons between study
arms (comparisons to control for efficacy proof, between
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level of 1.67% to keep an overall level of 5% for the total
primary analysis. The short-term assessment of the pri-
mary endpoint at T1 and all secondary endpoints at T1
or T2 will be analyzed using analogous models.
Methods against bias and data quality
Selection bias will be minimized by a standardized and
scrupulously followed recruitment procedure, supervised
by research assistants and monitored by the Clinical
Trial Center North of the University Hospital Hamburg-
Eppendorf (CTCN). The personnel of the participating
practices will not be involved in the collection of out-
come relevant data. Follow-up data will be obtained dir-
ectly by study centers. Clusters are randomized to
treatments to avoid selection bias. Practices and patient
recruitment will be closely monitored and regular prac-
tice visits will ensure good collaboration. Both partici-
pating physicians and their practice staff will be
compensated financially. Practice efforts for recruitment
and basis documentation procedures and tools (forms)
will be optimized for excellent usability.
Before start, the study was registered in a public Inter-
net trial archive (Current Controlled Trials Ltd,
ISRCTN01559032). The Clinical Trial Center North and
the University Hospital Hamburg-Eppendorf will moni-
tor the study. Good Clinical Practice guidelines and
CTCN standard operation procedures will be followed.
Ethical approval
The protocol was approved by the ethics committee of
the Rostock University Medical Center before recruit-
ment of physicians and patients on September 10th 2012
(A 2012–0108).
Patients will have to sign an informed consent form
prior to enrolment in the study. It is not expected that
participation in the study will expose the patients to
relevant risks. GPs, pediatricians, and patients will par-
ticipate voluntarily and will be allowed to abandon their
participation at any time and without giving reasons.
Discussion
The previously conducted CHANGE trial provides evi-
dence for the effectiveness of doctor-patient communi-
cation and patient empowerment for reducing antibiotic
prescriptions in German primary care. CHANGE-2 aims
at investigating the additional benefit of point-of-care
tests in this setting. Earlier research found positive
effects in the Netherlands [28,33]. As both countries
have a similar antibiotic prescription pattern, that is
comparatively low rates [38], we assume a similar effect
in Germany.
In fact, a recent international study analyzed the effect
of a multifaceted intervention that included training forappropriate use of antibiotics, posters and brochures for
patients, and access to POCTs. Communication training
was not included here. Whereas antibiotic prescription
rates were markedly reduced in countries with initially
high rates, no significant effects were found in low
prescribing countries [39]. This finding suggests that
distribution of information alone is not sufficient to fur-
ther reduce prescription rates in low prescription
countries.
Both proposed interventions (communication training
with and without POCT) do not aim at reducing anti-
biotic prescriptions at all costs, but on improving the
process of decision-making. This approach will ensure
that patients who might benefit from antibiotics will be
treated accordingly. In light of the current German aver-
age prescription rate of 50% there is significant room for
improvement: an antibiotic prescribing level of 10–15%
for acute RTI is in fact reasonable [40,41].
As the outcomes will be analyzed based on the data of
the AOK sickness fund, a comprehensive patient follow-
up is possible and ensures that adverse effects (e.g. hos-
pital admissions) can be monitored. Furthermore, the
follow-up will uncover patient migration, allowing for
the comparison of reconsultation rates. Since there is no
evidence on the interrelationship between reduced anti-
biotic prescriptions and severe complications due to bac-
terial infections, we particularly focus on this issue. If
data analysis will show a significant difference in hospital
admissions due to reduced antibiotic prescriptions, the
trial will be stopped. In addition, we will analyze all
spontaneous reports of adverse effects.
As far as limitations are concerned, there are potential
sources of selection bias: Firstly, physicians volunteering
to participate in our study might be likely to be those
most interested in and sensitized for the issue of anti-
biotic prescriptions. These physicians might be more
likely to change their prescription behavior than other
physicians. Secondly, as we will only include patients
insured with the health insurance AOK, a bias on the
patient level might be caused.
This trial will be the first randomized controlled trial
in Germany to evaluate the use of communication train-
ing and POCTs on antibiotic prescription rates for RTI.
We expect the results of this trial to have major impact
on antibiotic prescription strategies and practices in Ger-
many, both among GPs as well as pediatricians. The ap-
proach is simple to implement and might be used very
rapidly among the target group. This study will also
allow gaining more insights into the natural course of
RTI, a common but still under-researched illness. Pro-
vided that our intervention proves to be successful on a
large scale, we expect our findings to disseminate rapidly
among regional and national health insurances, profes-
sional societies, and networks.
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